Index
1 Market Overview of Acquired Infections Testing
1.1 Acquired Infections Testing Market Overview
1.1.1 Acquired Infections Testing Product Scope
1.1.2 Acquired Infections Testing Market Status and Outlook
1.2 Global Acquired Infections Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Acquired Infections Testing Market Size by Region (2018-2029)
1.4 Global Acquired Infections Testing Historic Market Size by Region (2018-2023)
1.5 Global Acquired Infections Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Acquired Infections Testing Market Size (2018-2029)
1.6.1 North America Acquired Infections Testing Market Size (2018-2029)
1.6.2 Europe Acquired Infections Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Acquired Infections Testing Market Size (2018-2029)
1.6.4 Latin America Acquired Infections Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Acquired Infections Testing Market Size (2018-2029)
2 Acquired Infections Testing Market by Type
2.1 Introduction
2.1.1 Disease Testing
2.1.2 Drug-Resistance Testing
2.2 Global Acquired Infections Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Acquired Infections Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Acquired Infections Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Acquired Infections Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Acquired Infections Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Acquired Infections Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Acquired Infections Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Acquired Infections Testing Revenue Breakdown by Type (2018-2029)
3 Acquired Infections Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Ambulatory Surgery Centers (ASC)
3.1.4 Others
3.2 Global Acquired Infections Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Acquired Infections Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Acquired Infections Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Acquired Infections Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Acquired Infections Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Acquired Infections Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Acquired Infections Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Acquired Infections Testing Revenue Breakdown by Application (2018-2029)
4 Acquired Infections Testing Competition Analysis by Players
4.1 Global Acquired Infections Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acquired Infections Testing as of 2022)
4.3 Date of Key Players Enter into Acquired Infections Testing Market
4.4 Global Top Players Acquired Infections Testing Headquarters and Area Served
4.5 Key Players Acquired Infections Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Acquired Infections Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Gen-Probe
5.1.1 Gen-Probe Profile
5.1.2 Gen-Probe Main Business
5.1.3 Gen-Probe Acquired Infections Testing Products, Services and Solutions
5.1.4 Gen-Probe Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Gen-Probe Recent Developments
5.2 Siemens AG
5.2.1 Siemens AG Profile
5.2.2 Siemens AG Main Business
5.2.3 Siemens AG Acquired Infections Testing Products, Services and Solutions
5.2.4 Siemens AG Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Siemens AG Recent Developments
5.3 Alere
5.3.1 Alere Profile
5.3.2 Alere Main Business
5.3.3 Alere Acquired Infections Testing Products, Services and Solutions
5.3.4 Alere Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Cephei Recent Developments
5.4 Cephei
5.4.1 Cephei Profile
5.4.2 Cephei Main Business
5.4.3 Cephei Acquired Infections Testing Products, Services and Solutions
5.4.4 Cephei Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Cephei Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Acquired Infections Testing Products, Services and Solutions
5.5.4 Roche Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Abbott Laboratories
5.6.1 Abbott Laboratories Profile
5.6.2 Abbott Laboratories Main Business
5.6.3 Abbott Laboratories Acquired Infections Testing Products, Services and Solutions
5.6.4 Abbott Laboratories Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Laboratories Recent Developments
5.7 Qiagen GmbH
5.7.1 Qiagen GmbH Profile
5.7.2 Qiagen GmbH Main Business
5.7.3 Qiagen GmbH Acquired Infections Testing Products, Services and Solutions
5.7.4 Qiagen GmbH Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Qiagen GmbH Recent Developments
5.8 Becton Dickinson
5.8.1 Becton Dickinson Profile
5.8.2 Becton Dickinson Main Business
5.8.3 Becton Dickinson Acquired Infections Testing Products, Services and Solutions
5.8.4 Becton Dickinson Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Becton Dickinson Recent Developments
5.9 Meridian Bioscience, Inc.
5.9.1 Meridian Bioscience, Inc. Profile
5.9.2 Meridian Bioscience, Inc. Main Business
5.9.3 Meridian Bioscience, Inc. Acquired Infections Testing Products, Services and Solutions
5.9.4 Meridian Bioscience, Inc. Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Meridian Bioscience, Inc. Recent Developments
5.10 bioMerieux
5.10.1 bioMerieux Profile
5.10.2 bioMerieux Main Business
5.10.3 bioMerieux Acquired Infections Testing Products, Services and Solutions
5.10.4 bioMerieux Acquired Infections Testing Revenue (US$ Million) & (2018-2023)
5.10.5 bioMerieux Recent Developments
6 North America
6.1 North America Acquired Infections Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Acquired Infections Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Acquired Infections Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Acquired Infections Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Acquired Infections Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Acquired Infections Testing Market Dynamics
11.1 Acquired Infections Testing Industry Trends
11.2 Acquired Infections Testing Market Drivers
11.3 Acquired Infections Testing Market Challenges
11.4 Acquired Infections Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List